Paper39875780
Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products.
Zu R and 13 others. Mol Neurobiol, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products. Papers, record 39875780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39875780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| NLR Family, Pyrin Domain-Containing 3 Protein | Major topic |
| Inflammasomes | Major topic |
| Biological Products | Major topic |
| Humans | |
| Animals |
Source PubMed
References160
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19292443 | Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. | J Agric Food Chem | 2009 | https://conductscience.org/library/papers/19292443 | PubMed |
| 2 | 36333711 | Salidroside reduces neuropathology in Alzheimer's disease models by targeting NRF2/SIRT3 pathway. | Cell Biosci | 2022 | https://conductscience.org/library/papers/36333711 | PubMed |
| 3 | 38341852 | SERTAD1 initiates NLRP3-mediated inflammasome activation through restricting NLRP3 polyubiquitination. | Cell Rep | 2024 | https://conductscience.org/library/papers/38341852 | PubMed |
| 4 | 33972740 | RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33972740 | PubMed |
| 5 | 36463893 | Lecanemab for Alzheimer's disease: tempering hype and hope. | Lancet | 2022 | https://conductscience.org/library/papers/36463893 | PubMed |
| 6 | 31678221 | Whole-cell biocatalytic, enzymatic and green chemistry methods for the production of resveratrol and its derivatives. | Biotechnol Adv | 2020 | https://conductscience.org/library/papers/31678221 | PubMed |
| 7 | 37172394 | TXNIP contributes to induction of pro-inflammatory phenotype and caspase-3 activation in astrocytes during Alzheimer's diseases. | Redox Biol | 2023 | https://conductscience.org/library/papers/37172394 | PubMed |
| 8 | 15113710 | Polyphenols: food sources and bioavailability. | Am J Clin Nutr | 2004 | https://conductscience.org/library/papers/15113710 | PubMed |
| 9 | 23116637 | Baicalin attenuates proinflammatory cytokine production in oxygen-glucose deprived challenged rat microglial cells by inhibiting TLR4 signaling pathway. | Int Immunopharmacol | 2012 | https://conductscience.org/library/papers/23116637 | PubMed |
| 10 | 12743238 | Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. | Neurology | 2003 | https://conductscience.org/library/papers/12743238 | PubMed |
| 11 | 33362539 | Salidroside Attenuates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice and Modulates Inflammation of the Gut-Brain Axis. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33362539 | PubMed |
| 12 | 28540288 | Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease. | Front Cell Dev Biol | 2017 | https://conductscience.org/library/papers/28540288 | PubMed |
| 13 | 34633804 | Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota. | J Agric Food Chem | 2021 | https://conductscience.org/library/papers/34633804 | PubMed |
| 14 | 37564636 | Salvianolic acid B ameliorates neuroinflammation and neuronal injury via blocking NLRP3 inflammasome and promoting SIRT1 in experimental subarachnoid hemorrhage. | Front Immunol | 2023 | https://conductscience.org/library/papers/37564636 | PubMed |
| 15 | 37913602 | Salvianolic acid B exerts protective effects against Aβ-induced neuroinflammation through the inhibition of NLRP3 inflammasome activation and switching of M1/M2 polarization. | Tissue Cell | 2023 | https://conductscience.org/library/papers/37913602 | PubMed |
| 16 | 23431291 | Analysis of safety from a human clinical trial with pterostilbene. | J Toxicol | 2013 | https://conductscience.org/library/papers/23431291 | PubMed |
| 17 | 22992592 | Endoplasmic reticulum-mitochondria contacts: function of the junction. | Nat Rev Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22992592 | PubMed |
| 18 | 21116625 | Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. | Cancer Chemother Pharmacol | 2011 | https://conductscience.org/library/papers/21116625 | PubMed |
| 19 | 37649422 | ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer's disease in APP/PS-1 mice. | Drug Dev Ind Pharm | 2023 | https://conductscience.org/library/papers/37649422 | PubMed |
| 20 | 1759558 | Neuropathological stageing of Alzheimer-related changes. | Acta Neuropathol | 1991 | https://conductscience.org/library/papers/1759558 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42646494 | NLRP3 Inflammasome and Inflammation-Related Proteins Expression Characterized in Non-Cultivated Versus Cultivated Peripheral Blood Cells of Patients with Amyotrophic Lateral Sclerosis. | NeuroSci | 2026 | https://conductscience.org/library/papers/42646494 | PubMed |
| 42389758 | Limitations of Current Therapies and Barriers in Alzheimer's Disease. | Arch Intern Med Res | 2026 | https://conductscience.org/library/papers/42389758 | PubMed |
| 42228338 | Decoding neuroinflammation: the critical role of NLRP3 inflammasome in Alzheimer's disease. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42228338 | PubMed |
| 42154340 | Neuroprotective effects of trans-anethole on AlCl₃-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42154340 | PubMed |
| 41964970 | NLRP3 Inflammasome Activation in Oxidative Stress: A Key Mechanism Driving Neuroinflammation. | Neuroimmunomodulation | 2026 | https://conductscience.org/library/papers/41964970 | PubMed |
| 40508016 | Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40508016 | PubMed |
| 40260242 | NLRP3 inflammasome in Alzheimer's disease: molecular mechanisms and emerging therapies. | Front Immunol | 2025 | https://conductscience.org/library/papers/40260242 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NLRP3 | 114548 | PubTator's text mining | https://conductscience.org/library/genes/114548 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39875780
GET https://conductscience.org/api/papers/v1/39875780/references?page=2